Converge Bio Seed · $6M raised · (2024)

Converge Bio is a Generative AI Lab for the Life Sciences that accelerates drug development through AI-powered innovations in discovery, molecule design, and manufacturing. Their platform offers solutions for antibody design and screening, gene expression optimization, and target and biomarker discovery. Converge Bio serves pharmaceutical and biotech companies seeking to create tomorrow's therapies today.